Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2016
Pharma News, 2016
New trial launched to test cancer vaccine
A new vaccine aimed at enabling the immune system to fight against advanced cancer is being trialled in London and Guildford.
This tiny bot glows to diagnose tuberculosis
Scientists have engineered nanoparticles to do all sorts of amazing things, from killing diseased cells in the body to creating a powerful water-resistant coating.
Abortion drug a possible cure for breast cancer: research
KUNMING, March 1 (Xinhua) -- Mifepristone (MIF), a common abortion drug, has been found to have an anti-tumor effect in triple-negative breast cancer (TNBC), the most malignant...
High stress levels cause cancer to spread: Australian study
MELBOURNE, March 2 (Xinhua) -- Australian researchers have established a link between high levels of stress and the spread of cancer, in a study that could affect the way doctors treat the dis...
FDA approves Roche’s Gazyva to treat follicular lymphoma
The US Food and Drug Administration (FDA) has granted approval for Roche's approved Gazyva (obinutuzumab) plus bendamustine chemotherapy, followed by Gazyva alone as a new treatmen...
Lupin plans to add plant in Japan
With Japan's government planning to shift the country toward using more generics to cut its burgeoning healthcare budget, analysts see a big opportunity for Indian generics companies like Sun Phar...
Antidepressant Paroxetine Shows Potential To Treat HIV-Linked Cognitive Impairment
HIV-linked cognitive impairment may soon be treated with an antidepressant that can reverse the condition.
AstraZeneca agrees licensing deal for Plendil in China
AstraZeneca has struck a $500m deal to sell the marketing rights for two heart drugs, in the latest example of the UK pharmaceuticals group using licensing agreements to boost flagging revenues.
Potential Huntington's Disease Drug Found Effective In Mice, Monkeys: Study
TORONTO.
Glyphosate weed killer found in German beers, study finds
Fourteen beers popular in Germany contain traces of glyphosate, the world's most widely used weed killer, a Munich environmental group has said.
World's first Dengue vaccine out
Dengue is one of the most devastating mosquito borne diseases in the world.
FDA Accepts Sanofi New Drug Application for Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide
PARIS, Feb.
46
47
48
49
50
51
52
53
54